Nature Reviews Urology
Nature Reviews Urology (commonly abbreviated as ''Nat. Rev. Urol.') is a urology review journal published by Nature Portfolio. It was launched in 2004, took its present title in April 2009 from Nature Clinical Practice Urology, is issued monthly and had a 2025 impact factor of 13.6.Nature Reviews Urology（常用缩写 Nat. Rev. Urol.）是 Nature Portfolio 旗下泌尿学领域的综述类期刊，创刊于 2004 年，2009 年 4 月由 Nature Clinical Practice Urology 改用现名，按月刊出版，2025 年影响因子为 13.6。[1]
Scope
- Disciplinary focus: the journal's basic, translational and clinical content is written by internationally renowned academics and researchers and is targeted at readers in the biological and medical sciences from postgraduate level upwards. Although it is intended to be read by practising doctors, researchers and academics within the specialty, the journal aims to make all of its articles accessible to readers working in any biological or medical discipline.学科定位： 期刊的基础、转化与临床内容由国际知名的基础与临床学者撰写，面向研究生及以上阶段的生物与医学读者。虽主要供本专业的执业医师、研究人员与学者阅读，但期刊力求让其他生物或医学学科的读者也能读懂每一篇文章。
- Subjects covered: the scope spans andrology, benign prostatic hyperplasia, bladder cancer, endourology and stones, female urology, fertility and infertility, penile, prostate, renal and testicular cancers, upper tract urothelial carcinoma, urinary tract infection and inflammation, imaging and radiology, biostatistics and clinical trials, trauma and reconstruction, transplantation, sexual dysfunction and sexual psychology, risk factors and epidemiology, paediatric urology and upper urinary tract dysfunction.选题范围： 覆盖男科、良性前列腺增生、膀胱癌、腔内泌尿外科与结石、女性泌尿外科、生育与不孕、阴茎癌、前列腺癌、肾癌、睾丸癌、上尿路尿路上皮癌等肿瘤方向，以及尿路感染与炎症、影像与放射、生物统计学与临床试验、创伤与重建、移植、性功能障碍与性心理、风险因素与流行病学、小儿泌尿外科与上尿路功能障碍等主题。
- Content types: the journal publishes in-depth Reviews, Perspectives, News & Views, Research Highlights, Comment and Consensus Statement formats, with the Research Highlights section filtering primary research out of a range of specialist and general medical journals.体裁： 刊发深度综述、观点、新闻与观点、研究亮点、评论与共识声明等体裁，其中研究亮点一节由编辑部从本领域各类专业期刊与综合医学期刊中筛选一级研究加以评述。
- Commissioned model: Reviews and Perspectives are commissioned by the editorial team from leaders in the field and undergo rigorous peer review, so complete unsolicited manuscripts are not published. Authors may submit Review-type and Comment-type proposals through the online submission system and these are considered, but the great majority of published content is commissioned.约稿定位： 综述与观点均由编辑部约请领域内的领军学者撰写并经严格同行评审，期刊不刊发作者直接投来的完整稿件。作者可在在线系统提交综述类与评论类的选题提案，编辑部也会考虑此类提案，但刊载内容以约稿为绝对主体。
- Reach beyond the specialty: alongside the professional audience, the journal deliberately covers issues that matter to urologists themselves, to patients and their families and to the general public globally. It writes and illustrates for accessibility, and has run official social media accounts so that editors and readers can engage directly.读者延伸： 除专业读者外，期刊也刻意覆盖泌尿科医师、患者及其家庭和全球公众关心的议题，行文与图示以易懂为先，2014 年前后并在社交平台开设官方账号，以便编辑与读者直接沟通。
- Open access: articles can only be published using the subscription route, and the publisher offers no immediate gold open access option and charges no publication fee. Six months after online publication, authors may self-archive the accepted manuscript on their personal website or in a funder or institutional repository.开放获取： 文章只能按订阅方式出版，出版方不提供立即开放获取选项，也不收取版面费。作者可在文章在线发表六个月后，将已接受的稿件存入个人主页或资助方与所属机构的知识库。
History
- November 2004: the journal was launched under the name Nature Clinical Practice Urology, with Peter Scardino, then chairman of urology at Memorial Sloan Kettering Cancer Center, as its first Editor-in-Chief. He set out its mission as producing articles that were reliable, relevant to the reader's practice, informative, balanced and objective.2004年11月： 期刊以 Nature Clinical Practice Urology 之名创刊，首任主编是纪念斯隆凯特琳癌症中心泌尿外科主任 Peter Scardino，他提出的办刊宗旨是让文章做到可靠、对读者实践有用、信息充分、平衡而客观。
- April 2009: the publisher rebranded eight clinical journals under the Nature Reviews name, taking the series from seven titles to fifteen. This journal took its present title Nature Reviews Urology at the same time, with print and online layouts fully redesigned.2009年4月： 出版方把八本临床类刊物统一改冠 Nature Reviews 品牌，系列规模由七本扩至十五本，本刊自此改用 Nature Reviews Urology 现名，印刷版与在线版的版式也随之全面重新设计。
- 2014: in its tenth-anniversary issue the journal commissioned six members of its external advisory board to take stock of the previous decade in renal cancer, sexual medicine, prostate cancer, bladder cancer, female urology and urological imaging, and ran a companion anniversary Viewpoint written by members of the board.2014年： 十周年纪念专辑中，编辑部约请六位外部顾问委员分别评述肾癌、性医学、前列腺癌、膀胱癌、女性泌尿外科与泌尿影像在十年间的变化，并同期刊出由编委成员撰写的周年观点文章。
- The 2020s: the journal has partnered with the men's health charity Movember on collaborative collections covering men's health and the Movember Global Action Plan, and has published a prostate cancer landscape analysis. It also maintains a relationship with the Urinary Tract Infection Global Alliance on a major source of antimicrobial resistance.2020年代： 期刊与男性健康公益组织 Movember 合作推出男性健康与全球行动计划两个合集并发表前列腺癌版图分析，又围绕尿路感染这一抗微生物耐药的重要来源与尿路感染全球联盟保持合作。
- The twentieth anniversary: two editorials in November 2024 reported close to 800 Reviews published over twenty years, tracing a shift from a purely clinical focus towards disease mechanisms, pathways and preclinical models, with biomarkers, particularly those obtained by non-invasive liquid biopsy, becoming a recurring subject.二十周年回顾： 2024 年 11 月的两篇社论指出，二十年间本刊已刊出近八百篇综述，取材重心随领域迁移而变化，从纯临床导向扩展到疾病机制、通路与临床前模型，生物标志物尤其是无创液体活检所得标志物已成为综述的常见主题。[2]
Editors
- Chief Editor: the journal is led by Annette Fenner PhD, who studied medicine and took an intercalated BSc and PhD in reproductive endocrinology at Imperial College London, working on hypothalamic peptides in the control of reproduction during her PhD. She joined as an Associate Editor in June 2010, was promoted to Chief Editor in 2011 and is based in the London office, with a particular interest in sexual medicine and andrology.主编： 现任主编为 Annette Fenner 博士。她在帝国理工学院完成医学学位并插入取得学士与生殖内分泌学博士学位，博士阶段研究下丘脑肽对生殖的调控，2010 年 6 月以副编辑身份加入本刊，2011 年升任主编，常驻伦敦办公室，研究兴趣集中于性医学与男科学。
- Senior and Associate Editors: Louise Lloyd PhD serves as Senior Editor. She studied at Bangor and Glasgow universities, worked as a research technician at the University of Birmingham and a research assistant at an institute of cell signalling in Nottingham, then returned to Birmingham to complete her PhD, joining as an Associate Editor in June 2014 and becoming Senior Editor in November 2016. Maria Chiara Masone PhD serves as an Associate Editor, having trained in biotechnology in Italy and studied membrane contact sites between the endoplasmic reticulum and the Golgi complex before moving to London to work in publishing in 2019, and joined the journal in September 2021.高级编辑与副编辑： Louise Lloyd 博士担任高级编辑。她在班戈尔大学与格拉斯哥大学求学，后在伯明翰大学任研究技术员、在诺丁汉大学细胞信号研究所任研究助理，再回伯明翰完成博士学位，2014 年 6 月以副编辑身份加入，2016 年 11 月升任高级编辑。Maria Chiara Masone 博士任副编辑，她在意大利完成生物技术训练并研究内质网与高尔基体之间的膜接触位点，2019 年赴伦敦转入出版业，2021 年 9 月加入本刊。
- External advisory board: unlike some titles in the series that have no external board, this journal maintains an external Advisory Board of clinicians and researchers that advises on content and emerging trends, six members of which each wrote a decade review for the tenth-anniversary issue in 2014.外部顾问委员会： 与同系列部分不设外部编委的刊物不同，本刊设有由临床医生与研究者组成的外部顾问委员会，为选题方向与新兴趋势提供建议，2014 年十周年专辑即由其中六位委员分别执笔十年回顾。
- How the team is organised: all editorial decisions are made by a team of full-time professional editors with PhD-level training based in London. A Reviews Cross-Journal Editorial Team works across the Nature Reviews portfolio, allocating resource among the life, clinical, physical and social sciences to handle topics falling outside the journal's own disciplinary boundaries.团队分工： 所有编辑决定由常驻伦敦的、具有博士学位的全职专业编辑团队集体作出，另有跨刊综述编辑团队在生命、临床、物理与社会科学各领域之间调配人手，以承接超出本刊学科边界的选题。
- Review and submission: manuscripts are commissioned by the editorial team and then reviewed by external experts, with a single-blind process in which reviewers may choose to sign their reports. Both general editorial inquiries and queries about manuscript status are handled directly by the editorial office at the contact addresses given on the journal's official pages.评审与投稿： 稿件由编辑部主动约请并送外部专家评审，采用单盲评审方式，审稿人可选择在评审报告上署名。一般编辑问询与稿件状态查询均由编辑部统一受理，联系方式以期刊官方页面所列为准。[3]